Dynavax Technologies News - DVAX

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Dynavax Technologies Corp DVAX NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.08 1.56% 5.21 5.15 5.49 5.26 5.13 20:00:00
more quote information »

Recent News

Date Time Source Heading
5/21/202021:00GLOBEDynavax Technologies Announces Pricing of $70.0 Million..
5/21/202016:01GLOBEDynavax Technologies Announces Proposed Public Offering of..
5/07/202016:10GLOBEDynavax Announces First Quarter 2020 Financial Results
4/28/202016:10GLOBEDynavax Reports Interim Analysis of Ongoing Clinical Trial..
4/23/202016:10GLOBEDynavax to Report First Quarter 2020 Financial Results and..
4/16/202007:30GLOBEDynavax and Sinovac Announce Collaboration to Develop a..
4/08/202008:00GLOBEDynavax Donates 10,000 Doses of HEPLISAV-B® [Hepatitis B..
4/07/202015:58EDGARProxy Statement - Notice of Shareholders Meeting..
4/03/202016:12EDGARCurrent Report Filing (8-k)
4/02/202016:30GLOBEDynavax Provides Business Update on COVID-19 Pandemic Impact
3/26/202007:30GLOBEDynavax and CEPI Announce Collaboration to Support Global..
3/24/202008:30GLOBEDynavax and Clover Biopharmaceuticals Announce Research..
3/16/202019:44EDGARStatement of Changes in Beneficial Ownership (4)
3/16/202019:42EDGARStatement of Changes in Beneficial Ownership (4)
3/12/202016:29EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
3/12/202016:24EDGARStatement of Changes in Beneficial Ownership (4)
3/11/202017:02EDGARPost-effective Amendment to Registration Statement (pos Am)
3/11/202016:23EDGARAnnual Report (10-k)
3/11/202016:16EDGARCurrent Report Filing (8-k)
3/11/202016:10GLOBEDynavax Announces Fourth Quarter and Full Year 2019..
3/02/202008:00GLOBEDynavax Announces Collaboration with the University of..
2/24/202016:05GLOBEDynavax to Report Fourth Quarter and Full Year 2019..
2/20/202017:33EDGARStatement of Changes in Beneficial Ownership (4)
2/18/202016:05GLOBEDynavax to Present at the Cowen 40th Annual Health Care..
2/15/202001:21EDGARCurrent Report Filing (8-k)
2/14/202018:51EDGARStatement of Changes in Beneficial Ownership (4)
2/14/202018:49EDGARStatement of Changes in Beneficial Ownership (4)
2/14/202018:47EDGARStatement of Changes in Beneficial Ownership (4)
2/14/202018:44EDGARStatement of Changes in Beneficial Ownership (4)
2/14/202018:42EDGARStatement of Changes in Beneficial Ownership (4)
2/14/202013:45EDGARAmended Statement of Ownership (sc 13g/a)
2/14/202011:22EDGARAmended Statement of Ownership (sc 13g/a)
2/14/202008:01EDGARAmended Statement of Ownership (sc 13g/a)
2/11/202016:45EDGARPost-effective Amendment to an Automatic Shelf Registration..
2/07/202016:11EDGARAmended Statement of Ownership (sc 13g/a)
2/05/202016:10EDGARAmended Statement of Ownership (sc 13g/a)
2/05/202011:49EDGARAmended Statement of Ownership (sc 13g/a)
2/04/202016:31EDGARAmended Statement of Ownership (sc 13g/a)
2/04/202016:11EDGARCurrent Report Filing (8-k)
12/17/201918:56EDGARStatement of Changes in Beneficial Ownership (4)
12/16/201916:46EDGARCurrent Report Filing (8-k)
12/16/201916:15GLOBEDynavax Appoints Ryan Spencer as Chief Executive Officer and..
12/05/201908:00GLOBEDynavax Announces Partnership with Albertsons Companies’..
12/03/201907:31EDGARCurrent Report Filing (8-k)
12/03/201907:00GLOBEDynavax Announces HEPLISAV-B Post-Marketing Requirement..
11/18/201916:07EDGARCurrent Report Filing (8-k)
11/07/201916:11EDGARQuarterly Report (10-q)
11/07/201916:05GLOBEDynavax to Present at the Stifel 2019 Healthcare Conference
11/07/201912:26EDGARConfidential Treatment Order (ct Order)
11/06/201916:16EDGARCurrent Report Filing (8-k)
See more news about this stock »

Your Recent History
Dynavax Te..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.